Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ADC Therapeutics SA (ADCT) vs Jyong Biotech Ltd. (MENS)

ADC Therapeutics SA and Jyong Biotech Ltd. are both Biotechnology companies. ADC Therapeutics SA and Jyong Biotech Ltd. are of similar size ($164.7M and $162.6M). Across the 4 metrics below, ADC Therapeutics SA leads on 2 and Jyong Biotech Ltd. on 2.

Valuation

Metric ADCT MENS Biotechnology median
P/E n/m — 7.88
P/S 2.47 — 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m — 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.19 n/m 10.73
Earnings yield (51.97%) — (28.84%)
Free cash flow yield (51.67%) — (23.03%)

Profitability

Metric ADCT MENS Biotechnology median
Gross margin 88.86% — 65.16%
Operating margin (125.08%) — 0.00%
Net margin (121.77%) — 0.00%
Free cash flow margin (127.72%) — 0.00%
Return on equity 45.35% — (57.72%)
Return on assets (32.25%) — (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADCT MENS Biotechnology median
Revenue growth (TTM) 3.03% — 5.64%
EPS growth (last fiscal year) 30.86% (42.18%) —
Revenue growth, 5-year CAGR 103.35% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADCT MENS Biotechnology median
Debt to equity (0.51) (0.74) 0.00
Current ratio 3.03 0.45 4.73
Net debt to EBITDA 1.22 (6.89) 0.96

Dividend

Metric ADCT MENS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ADCT MENS Biotechnology median
Market cap 164.69m 162.57m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack